Table 2.

Incidence and duration of new kidney replacement therapy and urea levels

W	AKI patients	High protein	Usual protein	p values
	(n = 312)	(n = 163)	(n = 149)
Duration of kidney replacement from randomization (among patients who received dialysis)* Median [IQR]	(107) 6.0 [3.0–10.0]	(60) 5.0 [2.0–10.0]	(47) 6.0 [4.0–10.0]	0.21
New KRT after randomization	64 (20.5%)	34 (20.9%)	30 (20.1%)	0.87
Average Urea (all patients) (mmol/L)	18.7 ± 9.8	19.7 ± 9.8	17.6 ± 9.7	0.04
Average urea ≥ 30 mmol/L (all patients)	42 (13.5%)	26 (16.0%)	16 (10.9%)	0.18

KRT, Kidney replacement therapy

*The duration of KRT from randomization includes 64 incident and 43 prevalent cases of KRT